Design and Synthesis of Indenoisoquinolines Targeting Topoisomerase I and Other Biological Macromolecules for Cancer Chemotherapy

Author(s):  
Mark Cushman
2005 ◽  
Vol 44 (7) ◽  
pp. 771-772 ◽  
Author(s):  
Thomas C. Yau ◽  
Kin W. Chu ◽  
Mo Y. Mok ◽  
Raymond H. Liang ◽  
Richard J. Epstein

ChemInform ◽  
2006 ◽  
Vol 37 (27) ◽  
Author(s):  
Andrew Morrell ◽  
Smitha Antony ◽  
Glenda Kohlhagen ◽  
Yves Pommier ◽  
Mark Cushman

2006 ◽  
Vol 16 (7) ◽  
pp. 1846-1849 ◽  
Author(s):  
Andrew Morrell ◽  
Smitha Antony ◽  
Glenda Kohlhagen ◽  
Yves Pommier ◽  
Mark Cushman

2019 ◽  
Vol 43 (14) ◽  
pp. 5475-5487 ◽  
Author(s):  
Imtiyaz Yousuf ◽  
Farukh Arjmand ◽  
Sartaj Tabassum ◽  
Musheer Ahmad

A half-sandwich organoruthenium(ii)–chromone complex acts as a potential topoisomerase I inhibitor.


2016 ◽  
Vol 40 (4) ◽  
pp. 3010-3013 ◽  
Author(s):  
B. Naumczuk ◽  
R. Kawęcki ◽  
J. Sitkowski ◽  
W. Bocian ◽  
E. Bednarek ◽  
...  

7-Ethyl-9-(N-morpholino)methyl-10-hydroxycamptothecin spontaneously binds covalently to 2′-deoxyguanosine under near-physiological conditions. This phenomenon may be important in the application of this type of camptothecin derivative in cancer chemotherapy.


ChemInform ◽  
2010 ◽  
Vol 41 (11) ◽  
pp. no-no
Author(s):  
Takeshi Ohta ◽  
Tsutomu Fukuda ◽  
Fumito Ishibashi ◽  
Masatomo Iwao

Sign in / Sign up

Export Citation Format

Share Document